beta-adrenoceptor blocking compounds , which are frequently used as first-line therapy in hypertension , may compromise blood flow to vital organs in view of the fact that they reduce cardiac output both acutely and during long-term treatment .
C0001643
beta-adrenoceptor
C0020538
hypertension